drugset / Trial / NCT01359514

Mechanism-based Choice of Therapy for Neuropathic Pain

NCT01359514

Completed 32 enrolled Rambam Health Care Campus
RandomizedParallel-groupTriple-blindTreatment

Summary

Mechanism-based choice of therapy for neuropathic pain: Can treatments success in neuropathic post-operative pain be coupled to psychophysical pain modulation profile?

Timeline

Start
2008-04
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 60 mg
Comparator Pregabalin Small molecule 150 mg

Indications

No indication recorded.